Tandlæge Per Gaunø Jensen ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  0.5% 0.5% 0.5% 0.5% 0.5%  
Bankruptcy risk  1.0% 1.0% 1.1% 1.5% 1.2%  
Credit score (0-100)  88 86 83 75 80  
Credit rating  A A A A A  
Credit limit (kDKK)  468.3 288.2 188.9 18.5 114.1  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  7,692 2,189 2,091 2,411 2,257  
EBITDA  950 233 164 445 134  
EBIT  776 43.0 -28.1 252 -31.0  
Pre-tax profit (PTP)  751.6 528.8 606.6 -386.0 421.7  
Net earnings  586.0 412.3 467.3 -302.3 329.1  
Pre-tax profit without non-rec. items  752 529 607 -386 422  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  898 791 647 503 390  
Shareholders equity total  4,165 4,522 4,932 4,573 4,843  
Interest-bearing liabilities  0.0 357 361 479 577  
Balance sheet total (assets)  5,923 5,508 6,066 5,465 5,885  

Net Debt  -3,906 -3,424 -4,053 -3,386 -3,952  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  7,692 2,189 2,091 2,411 2,257  
Gross profit growth  9.2% -71.5% -4.5% 15.3% -6.4%  
Employees  5 5 4 4 4  
Employee growth %  -58.3% 0.0% -20.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  5,923 5,508 6,066 5,465 5,885  
Balance sheet change%  9.8% -7.0% 10.1% -9.9% 7.7%  
Added value  949.5 233.2 163.7 443.6 133.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -3,391 -345 -336 -367 -329  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 -1.0 1.0 -1.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  10.1% 2.0% -1.3% 10.4% -1.4%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  13.8% 9.9% 11.2% 6.9% 8.3%  
ROI %  17.7% 12.0% 12.2% 7.5% 8.7%  
ROE %  15.0% 9.5% 9.9% -6.4% 7.0%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  69.1% 82.1% 81.3% 83.7% 82.3%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -411.4% -1,468.0% -2,476.3% -760.3% -2,957.9%  
Gearing %  0.0% 7.9% 7.3% 10.5% 11.9%  
Net interest  0 0 0 0 0  
Financing costs %  51.9% 21.7% 11.0% 187.0% 9.6%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  2.7 5.1 5.1 5.5 5.8  
Current Ratio  2.7 5.2 5.1 5.6 5.8  
Cash and cash equivalent  3,905.9 3,780.2 4,414.7 3,864.7 4,528.8  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  2,660.0 -180.6 -502.4 -128.7 -238.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  190 47 41 111 33  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  190 47 41 111 33  
EBIT / employee  155 9 -7 63 -8  
Net earnings / employee  117 82 117 -76 82